Enterprise Value
-$11.33 M
$0.000.00%
Tue, 25 Feb 2025 14:30:00 GMT
Summary
- As of February 26, 2025, ONCT enterprise value is -$11.33 million, unchanged from the previous trading day.
- Over the past year, ONCT enterprise value has dropped by -$32.36 million (-153.88%).
- ONCT enterprise value is now -101.61% below its all-time high of $703.61 million.
Performance
ONCT Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
ONCT Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | 0.0% | 0.0% |
| 1 m1 month | 0.0% | 0.0% | 0.0% |
| 3 m3 months | -6.3% | -30.3% | -30.3% |
| 6 m6 months | -259.3% | -88.3% | -88.3% |
| ytdytd | 0.0% | 0.0% | 0.0% |
| 1 y1 year | -153.9% | -94.3% | -94.3% |
| 5 y5 years | -126.7% | -97.5% | -99.3% |
ONCT Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -$11 M | at low | |
| 3 m | 3-month | -$11 M | -6.3% | -$11 M | at low |
| 6 m | 6-month | $8.50 M | -233.2% | -$11 M | at low |
| 1 y | 1-year | $26 M | -143.6% | -$11 M | at low |
| 3 y | 3-year | $38 M | -130.1% | -$48 M | +76.2% |
| 5 y | 5-year | $353 M | -103.2% | -$48 M | +76.2% |
| alltime | all time | $704 M | -101.6% | -$48 M | +76.2% |
Oncternal Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2025 | -$11.33 M(0.0%) |
| 2024 | -$11.33 M(-144.5%) |
| 2023 | $25.46 M(+24.7%) |
| 2022 | $20.41 M(-5.1%) |
| 2021 | $21.52 M(-82.4%) |
| 2020 | $122.43 M(+199.2%) |
| 2019 | $40.92 M(-530.9%) |
| 2018 | -$9.50 M(-103.7%) |
| 2017 | $258.03 M(+243.4%) |
| 2016 | $75.14 M(-10.8%) |
| 2015 | $84.24 M(-0.3%) |
| Date | Value |
|---|---|
| 2014 | $84.52 M(-5.7%) |
| 2013 | $89.65 M(-58.5%) |
| 2012 | $215.97 M(+46.4%) |
| 2011 | $147.55 M(+87.4%) |
| 2010 | $78.72 M(-30.1%) |
| 2009 | $112.66 M(-78.2%) |
| 2008 | $517.47 M(+23.2%) |
| 2007 | $420.15 M(-16.4%) |
| 2006 | $502.37 M(+214.2%) |
| 2005 | $159.91 M(-40.3%) |
| 2004 | $267.89 M |
FAQ
- What is Oncternal Therapeutics enterprise value?
- What is the all time high enterprise value for Oncternal Therapeutics?
- What is ONCT enterprise value year-to-date change?
- What is Oncternal Therapeutics enterprise value year-on-year change?
What is Oncternal Therapeutics enterprise value?
The current enterprise value of ONCT is -$11.33 M
What is the all time high enterprise value for Oncternal Therapeutics?
Oncternal Therapeutics all-time high enterprise value is $703.61 M
What is ONCT enterprise value year-to-date change?
Oncternal Therapeutics enterprise value has changed by $0.00 (0.00%) since the beginning of the year
What is Oncternal Therapeutics enterprise value year-on-year change?
Over the past year, ONCT enterprise value has changed by -$32.36 M (-153.88%)